Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shenglong Li

Showing results (61-70 of 177) with videos related to

Pageof 18
Sort By:
Journal of Nanobiotechnology|March 7, 2026
Multifunctional nanoplatforms deciphering immune resistance in bone tumors: cooperative delivery, immune reprogramming and microenvironment remodelingJiahang Li, Chao Yang, Liming Wang, et al.
Polymers|June 10, 2022
Application Status of Sacrificial Biomaterials in 3D BioprintingSiyu Liu, Tianlin Wang, Shenglong Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 8, 2023
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistanceXu Guo, Congying Gao, Dong-Hua Yang, et al.
Frontiers in Bioengineering and Biotechnology|January 29, 2025
Editorial: Research on nanomaterials in tumor diagnosis and therapyShi Bai, Yue Kang, Shenglong Li, et al.
Journal of Orthopaedic Surgery and Research|November 11, 2017
Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathwaysShenglong Li, Yujin Dong, Ke Wang, et al.
Acta Materia Medica|January 30, 2023
Functions and therapeutic potentials of exosomes in osteosarcomaJiaji Yue, Zhe-Sheng Chen, Xiang-Xi Xu, et al.
Lancet (London, England)|April 19, 2025
The need for expansion of global collaborations on AI in oncologyQiang Liu, Chuying Huang, Ge Zhan, et al.
Cancer Letters|April 22, 2026
Neutrophil Polarization Landscapes in HCC: From Immunosuppressive Niches to Antitumor Immunity ResuscitationJun Sun, Fan Yang, Yinyan Li, et al.
Oncology Reports|April 17, 2025
[Retracted] Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathwayPengfei Qiao, Shenglong Li, Haogang Zhang, et al.
Frontiers in Immunology|March 27, 2025
Single-cell and spatial transcriptomic analysis reveals tumor cell heterogeneity and underlying molecular program in colorectal cancerTeng Wang, Zhaoming Chen, Wang Wang, et al.
Pageof 18

Showing results (61-70 of 177) with videos related to

Sort By:
Pageof 18
Journal of Nanobiotechnology|March 7, 2026
Multifunctional nanoplatforms deciphering immune resistance in bone tumors: cooperative delivery, immune reprogramming and microenvironment remodelingJiahang Li, Chao Yang, Liming Wang, et al.
Polymers|June 10, 2022
Application Status of Sacrificial Biomaterials in 3D BioprintingSiyu Liu, Tianlin Wang, Shenglong Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 8, 2023
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistanceXu Guo, Congying Gao, Dong-Hua Yang, et al.
Frontiers in Bioengineering and Biotechnology|January 29, 2025
Editorial: Research on nanomaterials in tumor diagnosis and therapyShi Bai, Yue Kang, Shenglong Li, et al.
Journal of Orthopaedic Surgery and Research|November 11, 2017
Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathwaysShenglong Li, Yujin Dong, Ke Wang, et al.
Acta Materia Medica|January 30, 2023
Functions and therapeutic potentials of exosomes in osteosarcomaJiaji Yue, Zhe-Sheng Chen, Xiang-Xi Xu, et al.
Lancet (London, England)|April 19, 2025
The need for expansion of global collaborations on AI in oncologyQiang Liu, Chuying Huang, Ge Zhan, et al.
Cancer Letters|April 22, 2026
Neutrophil Polarization Landscapes in HCC: From Immunosuppressive Niches to Antitumor Immunity ResuscitationJun Sun, Fan Yang, Yinyan Li, et al.
Oncology Reports|April 17, 2025
[Retracted] Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathwayPengfei Qiao, Shenglong Li, Haogang Zhang, et al.
Frontiers in Immunology|March 27, 2025
Single-cell and spatial transcriptomic analysis reveals tumor cell heterogeneity and underlying molecular program in colorectal cancerTeng Wang, Zhaoming Chen, Wang Wang, et al.
Pageof 18